Replies to post #800 on Idenix Pharmaceuticals (IDIX)

[go seek]

estimate HBV worldwide sales as $1,000M in 2008


(see slide 6 and 7; slide 7 is latest edition of comparison sales link show as last item in this msg)
http://library.corporate-ir.net/library/13/131/131556/items/235629/CowenPresentation_031307.pdf

20% would be $200M
split w/ Novartis ... all else conservative estimate

$120M to Idenix in 2008 on Tyzeka sales

other relative info:
http://www.investorshub.com/boards/read_msg.asp?message_id=16670487

http://www.investorshub.com/boards/read_msg.asp?message_id=16480637

(October 06 sales info)
http://www.investorshub.com/boards/read_msg.asp?message_id=16968752